{"entity":{"type":"insider","cik":"0001601521","url":"/insider/0001601521","json_url":"/insider/0001601521.json","name":"De Rubertis Francesco","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":7,"first":"2014-07-09","last":"2021-12-06","span_basis":"filed_date"},"name_variants":[{"name":"De Rubertis Francesco","source":"filing","n_filings":7,"first_seen":"2014-07-09","last_seen":"2021-12-06"}],"transactions":[{"id":5492091,"accession":"0000899243-21-046972","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046972","line_url":"/filing/0000899243-21-046972","is_derivative":false,"issuer_cik":"0001601521","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001601521","owner_cik":"0001601521","owner_name":"De Rubertis Francesco","owner_display_name":"De Rubertis Francesco","owner_url":"/insider/0001601521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34326.0,"shares_display":"34,326","price_per_share":12.82,"price_display":"12.82","price_state":"stated","total_value":440059.32,"total_display":"440,059.32","total_whole":"440,059","shares_owned_after":3936970.0,"shares_owned_after_display":"3,936,970","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-06","scope":"insider","n_lines":2},{"id":4761927,"accession":"0000899243-21-046599","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-046599","line_url":"/filing/0000899243-21-046599","is_derivative":false,"issuer_cik":"0001601521","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001601521","owner_cik":"0001601521","owner_name":"De Rubertis Francesco","owner_display_name":"De Rubertis Francesco","owner_url":"/insider/0001601521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60304.0,"shares_display":"60,304","price_per_share":12.62,"price_display":"12.62","price_state":"stated","total_value":761036.48,"total_display":"761,036.48","total_whole":"761,036","shares_owned_after":3903440.0,"shares_owned_after_display":"3,903,440","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-02","scope":"insider","n_lines":2},{"id":4761919,"accession":"0000899243-21-046599","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046599","line_url":"/filing/0000899243-21-046599","is_derivative":false,"issuer_cik":"0001601521","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001601521","owner_cik":"0001601521","owner_name":"De Rubertis Francesco","owner_display_name":"De Rubertis Francesco","owner_url":"/insider/0001601521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36847.0,"shares_display":"36,847","price_per_share":11.62,"price_display":"11.62","price_state":"stated","total_value":428162.14,"total_display":"428,162.14","total_whole":"428,162","shares_owned_after":3844535.0,"shares_owned_after_display":"3,844,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-02","scope":"insider","n_lines":2},{"id":4088748,"accession":"0000899243-21-046320","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-046320","line_url":"/filing/0000899243-21-046320","is_derivative":false,"issuer_cik":"0001601521","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001601521","owner_cik":"0001601521","owner_name":"De Rubertis Francesco","owner_display_name":"De Rubertis Francesco","owner_url":"/insider/0001601521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56706.0,"shares_display":"56,706","price_per_share":11.7003,"price_display":"11.70","price_state":"stated","total_value":663477.2118,"total_display":"663,477.21","total_whole":"663,477","shares_owned_after":3808543.0,"shares_owned_after_display":"3,808,543","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-11-30","scope":"insider","n_lines":2},{"id":4088739,"accession":"0000899243-21-046320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046320","line_url":"/filing/0000899243-21-046320","is_derivative":false,"issuer_cik":"0001601521","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001601521","owner_cik":"0001601521","owner_name":"De Rubertis Francesco","owner_display_name":"De Rubertis Francesco","owner_url":"/insider/0001601521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11817.0,"shares_display":"11,817","price_per_share":11.3353,"price_display":"11.34","price_state":"stated","total_value":133949.2401,"total_display":"133,949.24","total_whole":"133,949","shares_owned_after":3753152.0,"shares_owned_after_display":"3,753,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-30","scope":"insider","n_lines":2},{"id":5132028,"accession":"0000899243-21-022071","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-022071","line_url":"/filing/0000899243-21-022071","is_derivative":false,"issuer_cik":"0001601521","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001601521","owner_cik":"0001601521","owner_name":"De Rubertis Francesco","owner_display_name":"De Rubertis Francesco","owner_url":"/insider/0001601521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":12000000.0,"total_display":"12,000,000.00","total_whole":"12,000,000","shares_owned_after":3741609.0,"shares_owned_after_display":"3,741,609","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider","n_lines":2},{"id":2286589,"accession":"0001140361-16-076141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-076141","line_url":"/filing/0001140361-16-076141#line-1","is_derivative":false,"issuer_cik":"0001598646","issuer_name":"Minerva Neurosciences, Inc.","issuer_ticker":"NERV","issuer_name_source":null,"issuer_url":"/issuer/0001598646","owner_cik":"0001601521","owner_name":"De Rubertis Francesco","owner_display_name":"De Rubertis Francesco","owner_url":"/insider/0001601521","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":4488272.0,"shares_owned_after_display":"4,488,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-10","filed_date":"2016-08-12","scope":"insider"},{"id":8924147,"accession":"0001140361-15-012777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-012777","line_url":"/filing/0001140361-15-012777#line-1","is_derivative":false,"issuer_cik":"0001598646","issuer_name":"Minerva Neurosciences, Inc.","issuer_ticker":"NERV","issuer_name_source":null,"issuer_url":"/issuer/0001598646","owner_cik":"0001601521","owner_name":"De Rubertis Francesco","owner_display_name":"De Rubertis Francesco","owner_url":"/insider/0001601521","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":202634.0,"shares_display":"202,634","price_per_share":4.81,"price_display":"4.81","price_state":"stated","total_value":974669.54,"total_display":"974,669.54","total_whole":"974,670","shares_owned_after":5488272.0,"shares_owned_after_display":"5,488,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-18","filed_date":"2015-03-20","scope":"insider"},{"id":6818138,"accession":"0001104659-14-050854","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-14-050854","line_url":"/filing/0001104659-14-050854","is_derivative":false,"issuer_cik":"0001598646","issuer_name":"Minerva Neurosciences, Inc.","issuer_ticker":"NERV","issuer_name_source":null,"issuer_url":"/issuer/0001598646","owner_cik":"0001601521","owner_name":"De Rubertis Francesco","owner_display_name":"De Rubertis Francesco","owner_url":"/insider/0001601521","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1620833.0,"shares_display":"1,620,833","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":9724998.0,"total_display":"9,724,998.00","total_whole":"9,724,998","shares_owned_after":4952305.0,"shares_owned_after_display":"4,952,305","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-07","filed_date":"2014-07-09","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847903","name":"Centessa Pharmaceuticals plc","url":"/issuer/0001847903","role":"Director","n_filings":4,"first_seen":"2021-06-04","last_seen":"2021-12-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001598646","name":"Minerva Neurosciences, Inc.","url":"/issuer/0001598646","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2014-07-09","last_seen":"2016-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001601521","retrieved_at":"2026-08-27T07:18:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}